Key opinion leaders review clinical cases in systemic mastocytosis, focusing on therapeutic options and diagnostic criteria.
EP. 1: Systemic Mastocytosis: Epidemiology and Diagnostic Criteria
Experts in the field of mast cell disorders discuss the epidemiology and diagnostic criteria of systemic mastocytosis.
EP. 2: Considerations in Mast Cell Disorders
The panel of experts highlights the importance of assessing symptomology and clinical characteristics in mast cell disorders.
EP. 3: Considerations in SM: Hereditary Alpha Tryptasemia
Prithviraj Bose, MD, and Patricia Lugar, MD, MS, discuss the considerations and testing options for hereditary alpha tryptasemia in patients with systemic mastocytosis.
EP. 4: Case 1: 75-Year-Old Man With SM
Dan DeAngelo, MD, PhD, presents the case of a 75-year-old man with systemic mastocytosis and reviews WHO diagnostic criteria.
EP. 5: Case 1: Treatment and Management Considerations
The panel of experts in SM discuss the diagnosis and management of a 75-year-old man with systemic mastocytosis.
EP. 6: Case 1: Treatment Algorithm and Supportive Care Recommendations
Patricia Lugar, MD, MS, shares treatment algorithm and supportive care recommendations for a 75-year-old man with systemic mastocytosis.
EP. 7: Case 2: 46-year-old Woman With SM
Dan DeAngelo, MD, PhD, presents the case of a 46-year-old woman with systemic mastocytosis and associated gastrointestinal symptoms.
EP. 8: Case 2: Treatment and Management Considerations for SM
The panel of experts in SM discuss the diagnosis and management of a 46-year-old woman with systemic mastocytosis.
EP. 9: Case 2: SM Treatment Algorithm and Supportive Care Recommendations
Patricia Lugar, MD, MS, shares an allergist’s perspective regarding treatment algorithms and supportive care recommendations for patients with systemic mastocytosis.
EP. 10: PATHFINDER Trial Efficacy Data
Dan DeAngelo, MD, PhD, reviews key efficacy data from the phase II PATHFINDER study.
EP. 11: Avapritinib: Approval and Clinical Practice Implications
A panel of experts share their reactions to the approval of avapritinib and discuss the clinical implications.
EP. 12: Case 3: Indolent Systemic Mastocytosis
Dan DeAngelo, MD, PhD, presents the case of a patient with indolent systemic mastocytosis and urticaria pigmentosa.
EP. 13: Case 4: A 68-Year-Old Female With Mast Cell Leukemia
Sa Wang, MD, presents the case of a 68-year-old female with mast cell leukemia.
EP. 14: Case 4: Treatment and Management Considerations in MCL
The panel of experts in SM discuss the diagnosis and treatment of a 68-year-old female with mast cell leukemia.
EP. 15: Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment
Learn more about the epidemiology, diagnosis, and treatment of advanced systemic mastocytosis in this summary from an expert multidisciplinary case-based discussion.
EP. 16: Case 5: A 24-Year-Old Female With Well-Differentiated SM
Sa Wang, MD, presents the case of a 24-year-old female with well-differentiated systemic mastocytosis.
EP. 17: Well-Differentiated Systemic Mastocytosis vs Chronic Mast Cell Leukemia
The panel of experts discuss the clinical differences between well-differentiated systemic mastocytosis and chronic mast cell leukemia.
EP. 18: Case 6: 47-Year-Old Male With Leukocytosis, Anemia, and Splenomegaly
Sa Wang, MD, presents the case of a 47-year-old male with leukocytosis, anemia, and splenomegaly.
EP. 19: Chronic Myelomonocytic Cell Leukemia: Clinical Considerations
The panel of experts discuss the diagnosis and assessment of chronic myelomonocytic cell leukemia.
EP. 20: Unmet Needs in SM Treatment
The panel of experts in SM highlight the unmet needs in the clinical care of systemic mastocytosis.
Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC
Zongertinib Elicits Durable Responses in Pretreated Advanced HER2-Mutant NSCLC
Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab
Sacituzumab Govitecan Does Not Significantly Improve OS in Pretreated Urothelial Carcinoma